Concepedia

Amir Snapir

AS

30

Publications

2.6K

Citations

20

H-Index

2001

Active since

Affiliations

Orion Corporation (Finland)(Current)

University of Turku

Tampere University Hospital

Institut Gustave Roussy

Amir Snapir is an author at Orion Corporation (Finland) specializing in medicine, pharmacology, and clinical trials.

Top concepts

Publications per year

2001–2021

30

Publications

30

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

Karim Fizazi, Neal D. Shore, Teuvo L.J. Tammela et al. · New England Journal of Medicine · 2019 · 890 citations · Full text

Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide

Karim Fizazi, Neal D. Shore, Teuvo L.J. Tammela et al. · New England Journal of Medicine · 2020 · 341 citations · Full text

Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep

Eero Huupponen, A. Maksimow, P Lapinlampi et al. · Acta Anaesthesiologica Scandinavica · 2007 · 321 citations

Effects of Low and High Plasma Concentrations of Dexmedetomidine on Myocardial Perfusion and Cardiac Function in Healthy Male Subjects

Amir Snapir, Jussi P. Posti, Erkki Kentala et al. · Anesthesiology · 2006 · 130 citations · Full text

An insertion/deletion polymorphism in the α2b-adrenergic receptor gene is a novel genetic risk factor for acute coronary events

Amir Snapir, Paula Heinonen, Tomi‐Pekka Tuomainen et al. · Journal of the American College of Cardiology · 2001 · 106 citations

, , +15

Rows per page

1–5 of 30